Drugs & medicalClass I

Amerisource Health Services LLC recalls Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, a).100-count bottle ( NDC 68001-396-00), b) 500-count…

Failed Dissolution Specifications

Read the official notice →
Date
2024-08-07
Country
United States
Brand
Amerisource Health Services
Product
Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, a).100-count bottle ( NDC 68001-396-00), b) 500-count bottle (NDC…
Classification
Class I
Units
US Nationwide.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Amerisource Health Services recalls

  1. 2025-01-15
  2. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC,…

    Presence of Foreign Tablets/Capsules

    FDA · DrugAmerisource Health Services LLCNationwide within the United StatesOfficial notice →
  3. 2025-01-01
  4. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited,…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
  5. 2024-12-11
  6. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited,…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

    FDA · DrugAmerisource Health Services LLCPA, OH, PROfficial notice →
  7. 2024-07-17
  8. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only,…

    Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
  9. 2024-02-14
  10. US
    Drugs & medicalClass III

    Amerisource Health Services LLC recalls HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health…

    Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
  11. US
All 31 Amerisource Health Services recalls →

Other drugs & medical recalls in the United States

  1. 2024-08-07
  2. US
    Drugs & medicalClass I

    Endo Pharmaceuticals, Inc. recalls Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx…

    Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.

    FDA · DrugEndo Pharmaceuticals, Inc.Nationwide in the USA and Puerto RicoOfficial notice →
  3. US
  4. US
    Drugs & medicalClass I

    SoloVital recalls Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

    Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

    FDA · DrugSoloVitalNationwide within the United StatesOfficial notice →
  5. 2024-07-31
  6. US
    Drugs & medicalClass II

    LINK BIO CORP recalls LINK SymphoKnee Patella Sizing Template, Item Number 881-509/00

    The LinkSymphoKnee Patella Sizing Template was incorrectly labeled. The markings on two arms of the instrument were mixed up because the triangular Patella Sizing Template was inserted upside down into the laser…

    FDA · DeviceLINK BIO CORPUS Nationwide distribution in the states of FL, GA, KS, OH, WI.Official notice →
  7. US
    Drugs & medicalClass II

    Siemens Medical Solutions USA, Inc recalls Sensis Vibe systems with software version VD15B in combination with Sensis High End Server -Intended to be used as a…

    If the Sensis documentation functionality is used during adding of once-per-study reporting events (e.g., Type 1 events, as further defined in the administrator manual), the possibility exists that the application…

    FDA · DeviceSiemens Medical Solutions USA, IncUS Nationwide distribution in the states of CA, CT, FL, IA, KS, MA, MI, NJ,…Official notice →
  8. US
    Drugs & medicalClass II

    B Braun Medical Inc recalls Brand Name: Perfusor Space Product Name: Perfusor Space Syringe Pump, Wireless Model/Catalog Number: 8713031U Software Version: 8713031U…

    Perfusor Space Syringe Pump's instructions for use previously identified Monoject syringes as an option for use. However, changes to manufacturing to Cardinal Health Monoject syringes may result in issues with…

    FDA · DeviceB Braun Medical IncDomestic distribution nationwide. International distribution to Canada.Official notice →
See all drugs & medical recalls →